Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Comprehensive Analysis Supports SERMs for Cutting Breast Cancer
Meta-analysis shows reduced incidence of breast cancer, especially in first five years of follow-up
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

December 22, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Approves Lynparza for Advanced Ovarian Cancer

Cancer Treatment Costs Creating 'Financial Toxicity' for Patients

Tips Offered to Docs, Spouses for Maintaining Happy Marriage

CDC: Not Too Late, or Too Futile, to Get Flu Vaccine

Prostaglandin Analogue Drops Preserve Vision in Glaucoma

Evidence Plays Limited Role in OTC Decision Making